Clinical Trial Update: Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared bromfenac ophthalmic solution 0.09%, diclofenac sodium ophthalmic solution 0.1%, and ketorolac tromethamine ophthalmic solutio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudophakic Cystoid Macular Edema

Drugs mentioned

• Bromfenac Ophthalmic Solution (bromfenac sodium)
• Diclofenac sodium ophthalmic solution (diclofenac sodium)
• Ketorolac tromethamine ophthalmic solution (ketorolac tromethamine)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Acute Pseudophakic Cystoid Macular Edema | Phase 4 | Status: COMPLETED